Pathogenesis diabetic microangiopathy overview Major susceptibility factors diabetic microangiopathy duration disease quality metabolic control mechanism development microangiopathy understood functional abnormalities microcirculation glucose metabolism hemostatic abnormality genetic susceptibility article factors pathogenesis attempts sequence pathogenic interactions microvascular changes susceptible target organs Possibilities therapeutic intervention pathogenic mechanisms small pilot trial oral hypoglycemic agent gliclazide evidence specific action drug thromboxane synthesis platelet aggregation independent glycemic control part fall lipid peroxides 